These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
844 results:

  • 1. Ganglioglioma with
    Zhao C; Li C; Ge JJ; Zhang JP
    Br J Hosp Med (Lond); 2024 Oct; 85(10):1-10. PubMed ID: 39475028
    [No Abstract]    [Full Text] [Related]  

  • 2. Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.
    Knudsen AM; Ewald JD; Pedersen V; Haupt-Jorgensen M; Hansen EVR; Kristensen BW
    Neuropathol Appl Neurobiol; 2024 Oct; 50(5):e13012. PubMed ID: 39449228
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary Mast cell Sarcoma of the Maxillary Sinus and Gingiva Mimicking Malignant Neuroendocrine tumor: A Case Report.
    Cheng TC; Chen JR; Wang RC; Chang KC; Hang JF
    Head Neck Pathol; 2024 Oct; 18(1):97. PubMed ID: 39404971
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Automated manufacturing and characterization of clinical grade autologous cd20 CAR T cells for the treatment of patients with stage III/IV melanoma.
    Aleksandrova K; Leise J; Priesner C; Aktas M; Apel M; Assenmacher M; Bürger I; Richter A; Altefrohne P; Schubert C; Holzinger A; Barden M; Bezler V; von Bergwelt-Baildon M; Borchmann P; Goudeva L; Glienke W; Arseniev L; Esser R; Abken H; Koehl U
    Front Immunol; 2024; 15():1328368. PubMed ID: 39386211
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Eslicarbazepine induces apoptosis and cell cycle arrest in C6 glioma cells in vitro and suppresses tumor growth in an intracranial rat model.
    Afsordeh N; Pournajaf S; Bayat H; Mohajerani F; Shojaei A; Mirnajafi-Zadeh J; Pourgholami MH
    BMC Cancer; 2024 Sep; 24(1):1099. PubMed ID: 39232721
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib).
    Kot M; Simiczyjew A; Wądzyńska J; Ziętek M; Matkowski R; Nowak D
    Cell Commun Signal; 2024 Aug; 22(1):410. PubMed ID: 39175042
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Combined underwater endoscopic and microscopic surgery for tympanic paraganglioma: A case report.
    Takata Y; Anzai T; Sonoda K; Okada H; Ishimizu E; Nakamura M; Hara S; Nakayama T; Matsumoto F
    Sci Prog; 2024; 107(3):368504241263524. PubMed ID: 39043202
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Papillary tumor of the pineal region: analysis of DNA methylation profiles and clinical outcomes in 76 cases.
    Wu Z; Dazelle K; Abdullaev Z; Chung HJ; Dahiya S; Wood M; Lee H; Lucas CG; Mao Q; Robinson L; Fernandes I; McCord M; Pytel P; Conway KS; Yoda R; Eschbacher JM; Maher OM; Hasselblatt M; Mobley BC; Raisanen JM; Hatanpaa KJ; Byers J; Lehman NL; Cimino PJ; Pratt D; Quezado M; Aldape K
    Acta Neuropathol Commun; 2024 Jul; 12(1):117. PubMed ID: 39014393
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exosomal miR-19a derived from melanoma cell promotes the vemurafenib resistance of malignant melanoma through directly targeting LRIG1 to reactivate AKT and MAPK pathway.
    Luan W; Lu X; Peng H; Shen X; Rao M; Ruan H
    Pathol Res Pract; 2024 Aug; 260():155410. PubMed ID: 38955119
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The causal relationship between immune cells mediating FIT3L, CCL4, OSM, and skin-derived deteriorated tumors.
    Gong W; Zhou J; Hou Y; Zhang J; He P; Yu Q
    Skin Res Technol; 2024 Jul; 30(7):e13774. PubMed ID: 38953214
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CD40 agonist engineered immunosomes modulated tumor microenvironment and showed pro-immunogenic response, reduced toxicity, and tumor free survival in mice bearing glioblastoma.
    Gaur V; Tyagi W; Das S; Ganguly S; Bhattacharyya J
    Biomaterials; 2024 Dec; 311():122688. PubMed ID: 38943821
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Regulation and molecular mechanism of adiponectin on the proliferation, apoptosis, autophagy, and chemosensitivity of LN18 Glioma cell line.
    Sun P; Huo K; Liu F; Cheng Y; Chen C; Han J; Yu J
    Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):178-186. PubMed ID: 38836664
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
    Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
    Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential.
    Ceci C; Ruffini F; Falconi M; Atzori MG; Falzon A; Lozzi F; Iacovelli F; D'Atri S; Graziani G; Lacal PM
    Biomed Pharmacother; 2024 Jul; 176():116766. PubMed ID: 38788599
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis.
    Barbosa LC; Machado GC; Heringer M; Ferrer VP
    Neurogenetics; 2024 Jul; 25(3):249-262. PubMed ID: 38775886
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic medicine advances for brain tumors.
    Koizumi S; Oishi T; Iwaizumi M; Kurozumi K
    Int J Clin Oncol; 2024 Oct; 29(10):1407-1416. PubMed ID: 38727852
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer cell Lines.
    Soleiman M; Fathi-Roudsari M; Khajeh K; Maghsoudi A
    Cancer Invest; 2024 Apr; 42(4):319-332. PubMed ID: 38695671
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
    Versluis JM; Blankenstein SA; Dimitriadis P; Wilmott JS; Elens R; Blokx WAM; van Houdt W; Menzies AM; Schrage YM; Wouters MWJM; Sanders J; Broeks A; Scolyer RA; Suijkerbuijk KPM; Long GV; Akkooi ACJV; Blank CU
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38677880
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. LKB1 prevents ILC2 exhaustion to enhance antitumor immunity.
    Niu H; Zhang H; Wang D; Zhao L; Zhang Y; Zhou W; Zhang J; Su X; Sun J; Su B; Qiu J; Shen L
    Cell Rep; 2024 May; 43(5):113579. PubMed ID: 38670109
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evaluating the human neurotoxicity and toxicological interactions impact of co-occurring regulated and emerging mycotoxins.
    de Sá SVM; Sousa Monteiro C; Fernandes JO; Pinto E; Faria MA; Cunha SC
    Food Res Int; 2024 May; 184():114239. PubMed ID: 38609220
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 43.